AS

ASKA Pharmaceutical Holdings CO., Ltd.

Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.

4886 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区芝浦二丁目5番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ASKA Pharmaceutical Holdings Co., Ltd. is the holding company for the ASKA Pharmaceutical Group, established in April 2021. The group's core business encompasses the research, development, manufacturing, and sale of pharmaceuticals. Leveraging its long-standing expertise in hormone-related technologies, the company focuses on developing innovative and original medicines, with a particular strength in therapeutic areas such as internal medicine, obstetrics and gynecology, and urology. The group's operations also extend to the animal health and hormone testing businesses.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ASKA Pharmaceutical Holdings CO., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-27 08:15
Regulatory News Service
臨時報告書
Japanese 31.4 KB
2025-06-20 08:11
Regulatory News Service
確認書
Japanese 8.2 KB
2025-06-20 08:10
Regulatory News Service
内部統制報告書-第4期(2024/04/01-2025/03/31)
Japanese 28.7 KB
2025-06-20 08:08
Annual Report
有価証券報告書-第4期(2024/04/01-2025/03/31)
Japanese 1.4 MB
2025-02-07 07:41
Regulatory News Service
臨時報告書
Japanese 21.4 KB
2024-11-08 07:04
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-08 07:02
Interim Report
半期報告書-第4期(2024/04/01-2025/03/31)
Japanese 183.3 KB
2024-06-28 07:12
Regulatory News Service
臨時報告書
Japanese 22.0 KB
2024-06-25 06:40
Regulatory News Service
確認書
Japanese 8.2 KB
2024-06-25 06:39
Regulatory News Service
内部統制報告書-第3期(2023/04/01-2024/03/31)
Japanese 23.6 KB
2024-06-25 06:37
Annual Report
有価証券報告書-第3期(2023/04/01-2024/03/31)
Japanese 1.3 MB
2024-02-09 07:07
Regulatory News Service
確認書
Japanese 8.1 KB
2024-02-09 07:05
Quarterly Report
四半期報告書-第3期第3四半期(2023/10/01-2023/12/31)
Japanese 155.2 KB
2023-11-10 07:23
Regulatory News Service
確認書
Japanese 8.1 KB
2023-11-10 07:18
Quarterly Report
四半期報告書-第3期第2四半期(2023/07/01-2023/09/30)
Japanese 183.9 KB

Automate Your Workflow. Get a real-time feed of all ASKA Pharmaceutical Holdings CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ASKA Pharmaceutical Holdings CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden BIOVIC
BOIRON Logo
Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.
France BOI
Bosnalijek d.d. Sarajevo Logo
Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.
Bosnia and Herzegovina BSNL
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden CALTX
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom CNSL
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575

Talk to a Data Expert

Have a question? We'll get back to you promptly.